IBM remains top software name as with AI, quantum momentum driving upside, Wedbush says

Wedbush analysts have raised their price target for IBM from $300 to $325, maintaining an 'Outperform' rating, citing the company's strong position in the AI revolution and surging enterprise demand for AI and hybrid cloud solutions. IBM's $6 billion-plus generative AI book of business and advancements in quantum computing, including the Quantum Starling project and the upcoming Quantum Nighthawk chip, underpin Wedbush's bullish outlook, despite the stock's 28% year-to-date increase.

Analysis

Wedbush has reiterated its 'Outperform' rating on International Business Machines Corp (IBM) and increased its price target from $300 to $325, underscoring a bullish stance driven by IBM's strategic positioning within the accelerating AI revolution and robust enterprise demand for AI and hybrid cloud solutions. The analysts highlight IBM's significant $6 billion-plus generative AI (GenAI) book of business as a key growth driver, noting successful integration of AI into over 70 enterprise workflows across sales, finance, and marketing, further enhanced by synergies from Red Hat and HashiCorp integrations. Despite a 28% surge in IBM's stock year-to-date to approximately $282, Wedbush believes the stock remains "under owned" and offers further upside. Beyond immediate AI opportunities, IBM's advancements in quantum computing, including its Quantum Starling project aiming for a fault-tolerant quantum computer with 100 million gates and 200 logical qubits, and the upcoming Quantum Nighthawk chip, contribute to the positive long-term outlook by positioning IBM to capitalize on the nascent multi-billion-dollar quantum computing industry.

Key Decisions for Investors

• Investors should consider IBM's potential for continued appreciation given Wedbush's increased price target and the company's strong foothold in the high-growth AI and hybrid cloud markets.
• It is prudent to monitor IBM's execution in commercializing its GenAI offerings and the progress of its quantum computing roadmap, particularly the Quantum Starling and Nighthawk initiatives, as key catalysts.
• Despite the stock's notable 28% year-to-date gain, the assessment that IBM remains 'under owned' suggests further institutional interest could drive shares higher, meriting evaluation for portfolio inclusion or position adjustment.